Filing Flows

Filing Flows › Guardian Pharmacy Services (GRDN) › Q2 2025

Guardian Pharmacy Services (GRDN) Q2 2025 earnings results (second quarter 2025)

10-Q filed Aug 11, 2025

Guardian Pharmacy Services (GRDN) reported revenue of $344M for the second quarter 2025 (Q2 2025), +15% from a year earlier and +5% from the quarter before. Operating margin was 3.7%, net earnings $9.0M (2.6% of revenue).

Revenue$344M
Year over year+15%
Quarter over quarter+5%
Operating margin3.7%
Net earnings$9.0M

Guardian Pharmacy Services, Q2 2025: revenue $344M (+15% year over year), operating margin 3.7%, net earnings $9.0M, operating cash flow $19.9M. The chart follows the revenue to costs, profit and cash.

Q2 2025AmountQ/QY/Y
Revenue$344M+5%+15%
Gross profit$68.1M+6%+11%
Operating profit$12.6M-3%-26%
Net earnings$9.0M-4%—
Operating cash flow$19.9M+14%-32%

What changed

Revenue was $344.3M in Q2 2025, up 15% year over year and up 5% from the previous quarter.

Gross margin was 19.8%, down 0.6 points from a year earlier. Operating profit was $12.6M, a 3.7% margin (down 2.0 points year over year). Operating profit fell $4.4M even though revenue rose $44.3M versus a year earlier, so costs grew faster than sales. Operating expenses grew 25% against revenue growth of 15%. Net earnings were $9.0M. The effective tax rate was 29.9%.

Operating cash flow was $19.9M (down 32% year over year), 226% of net income including minority interests. Non-cash charges added back $5.5M of depreciation and amortization and $4.4M of share-based compensation. Working capital and other items added $1.2M.

Questions

What was Guardian Pharmacy Services' revenue in the second quarter 2025?

Guardian Pharmacy Services (GRDN) reported revenue of $344M for the second quarter 2025 (Q2 2025), +15% from a year earlier and +5% from the quarter before.

Was Guardian Pharmacy Services profitable in the second quarter 2025?

Operating profit was $12.6M (3.7% of revenue) and net earnings $9.0M.

Open the interactive Sankey →

Source: Guardian Pharmacy Services 10-Q on SEC EDGAR.